831 related articles for article (PubMed ID: 21659605)
1. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.
Yu Y; Yoon SO; Poulogiannis G; Yang Q; Ma XM; Villén J; Kubica N; Hoffman GR; Cantley LC; Gygi SP; Blenis J
Science; 2011 Jun; 332(6035):1322-6. PubMed ID: 21659605
[TBL] [Abstract][Full Text] [Related]
2. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.
Hsu PP; Kang SA; Rameseder J; Zhang Y; Ottina KA; Lim D; Peterson TR; Choi Y; Gray NS; Yaffe MB; Marto JA; Sabatini DM
Science; 2011 Jun; 332(6035):1317-22. PubMed ID: 21659604
[TBL] [Abstract][Full Text] [Related]
3. Grb10 promotes lipolysis and thermogenesis by phosphorylation-dependent feedback inhibition of mTORC1.
Liu M; Bai J; He S; Villarreal R; Hu D; Zhang C; Yang X; Liang H; Slaga TJ; Yu Y; Zhou Z; Blenis J; Scherer PE; Dong LQ; Liu F
Cell Metab; 2014 Jun; 19(6):967-80. PubMed ID: 24746805
[TBL] [Abstract][Full Text] [Related]
4. Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth.
Acosta-Jaquez HA; Keller JA; Foster KG; Ekim B; Soliman GA; Feener EP; Ballif BA; Fingar DC
Mol Cell Biol; 2009 Aug; 29(15):4308-24. PubMed ID: 19487463
[TBL] [Abstract][Full Text] [Related]
5. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
Yoon MS
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
[TBL] [Abstract][Full Text] [Related]
6. Role of Grb10 in mTORC1-dependent regulation of insulin signaling and action in human skeletal muscle cells.
Edick AM; Auclair O; Burgos SA
Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E173-E183. PubMed ID: 31794259
[TBL] [Abstract][Full Text] [Related]
7. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909
[TBL] [Abstract][Full Text] [Related]
8. Proproliferative function of adaptor protein GRB10 in prostate carcinoma.
Khan MI; Al Johani A; Hamid A; Ateeq B; Manzar N; Adhami VM; Lall RK; Rath S; Sechi M; Siddiqui IA; Choudhry H; Zamzami MA; Havighurst TC; Huang W; Ntambi JM; Mukhtar H
FASEB J; 2019 Mar; 33(3):3198-3211. PubMed ID: 30379590
[TBL] [Abstract][Full Text] [Related]
9. The TORC1-activated Proteins, p70S6K and GRB10, Regulate IL-4 Signaling and M2 Macrophage Polarization by Modulating Phosphorylation of Insulin Receptor Substrate-2.
Warren KJ; Fang X; Gowda NM; Thompson JJ; Heller NM
J Biol Chem; 2016 Nov; 291(48):24922-24930. PubMed ID: 27742835
[TBL] [Abstract][Full Text] [Related]
10. Functional Proteomics Identifies Acinus L as a Direct Insulin- and Amino Acid-Dependent Mammalian Target of Rapamycin Complex 1 (mTORC1) Substrate.
Schwarz JJ; Wiese H; Tölle RC; Zarei M; Dengjel J; Warscheid B; Thedieck K
Mol Cell Proteomics; 2015 Aug; 14(8):2042-55. PubMed ID: 25907765
[TBL] [Abstract][Full Text] [Related]
11. mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action.
Soliman GA; Acosta-Jaquez HA; Dunlop EA; Ekim B; Maj NE; Tee AR; Fingar DC
J Biol Chem; 2010 Mar; 285(11):7866-79. PubMed ID: 20022946
[TBL] [Abstract][Full Text] [Related]
12. Cell signaling. New mTOR targets Grb attention.
Yea SS; Fruman DA
Science; 2011 Jun; 332(6035):1270-1. PubMed ID: 21659593
[No Abstract] [Full Text] [Related]
13. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity.
Liu L; Luo Y; Chen L; Shen T; Xu B; Chen W; Zhou H; Han X; Huang S
J Biol Chem; 2010 Dec; 285(49):38362-73. PubMed ID: 20937815
[TBL] [Abstract][Full Text] [Related]
14. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
15. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma.
Jhanwar-Uniyal M; Dominguez JF; Mohan AL; Tobias ME; Gandhi CD
Adv Biol Regul; 2022 Jan; 83():100854. PubMed ID: 34996736
[TBL] [Abstract][Full Text] [Related]
16. mTORC1 signaling can regulate growth factor activation of p44/42 mitogen-activated protein kinases through protein phosphatase 2A.
Harwood FC; Shu L; Houghton PJ
J Biol Chem; 2008 Feb; 283(5):2575-85. PubMed ID: 18056704
[TBL] [Abstract][Full Text] [Related]
17. Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action.
Deng Y; Bhattacharya S; Swamy OR; Tandon R; Wang Y; Janda R; Riedel H
J Biol Chem; 2003 Oct; 278(41):39311-22. PubMed ID: 12783867
[TBL] [Abstract][Full Text] [Related]
18. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 inhibition increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON.
Li J; Liu J; Song J; Wang X; Weiss HL; Townsend CM; Gao T; Evers BM
Am J Physiol Cell Physiol; 2011 Jul; 301(1):C213-26. PubMed ID: 21508335
[TBL] [Abstract][Full Text] [Related]
20. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).
García-Martínez JM; Alessi DR
Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]